13F-HR filed by Palo Alto Investors LP
Palo Alto Investors LP filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 40 holding rows worth $2,374,127,000.
- Accession
- 0001306923-17-000025
- Filer
- CIK 1306923
- Filed
- 2017-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2017
A holdings report, 40 entries on the cover page, a total value of $2,374,127,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,374,127,000 with VALUE read as thousands by filing date, 13F file number 028-11013. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIOMED INC | 003654100 | COM | 1,935,300 | $326,292,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 3,329,581 | $274,357,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 2,438,519 | $226,953,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 1,762,650 | $206,565,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 6,171,816 | $192,622,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 1,080,342 | $151,561,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 6,398,296 | $121,888,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 7,420,288 | $111,898,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 4,155,670 | $74,386,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,095,655 | $70,966,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 2,676,393 | $69,238,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 3,441,233 | $63,491,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,641,030 | $61,818,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 787,251 | $49,046,000 | thousands by filing date | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 3,507,052 | $43,663,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 295,240 | $43,052,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 3,010,466 | $42,086,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 223,107 | $41,558,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 3,498,585 | $38,414,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 1,794,998 | $33,207,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 1,293,764 | $32,072,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 433,076 | $20,407,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 130,200 | $19,939,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 175,900 | $14,251,000 | thousands by filing date | |
| BIOVERATIV INC | 09075E100 | COM | 211,300 | $12,059,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 3,855,024 | $9,792,000 | thousands by filing date | |
| ACELRX PHARMACEUTICALS INC | 00444T100 | COM | 1,032,715 | $4,750,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 3,013,793 | $4,069,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 500,913 | $2,880,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 1,162,473 | $2,255,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 123,686 | $1,793,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 616,355 | $1,374,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 340,320 | $1,106,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 29,500 | $1,034,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 341,300 | $870,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 64,400 | $789,000 | thousands by filing date | |
| Ocugen | 43358V109 | Common | 302,922 | $600,000 | thousands by filing date | |
| SOPHIRIS BIO INC F | 83578Q209 | FOREIGN CANADIAN | 247,000 | $530,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 272,788 | $276,000 | thousands by filing date | |
| SOLENO THERAPEUTICS INC | 834203101 | COM | 84,748 | $220,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001306923-17-000025 | this filing | 2017-11-14 | acceptance time not in the bulk data set |